行情

MRK

MRK

默克
NYSE

实时行情|Nasdaq Last Sale

84.65
+0.52
+0.62%
已收盘, 17:10 11/19 EST
开盘
84.40
昨收
84.13
最高
84.95
最低
83.97
成交量
924.75万
成交额
--
52周最高
87.35
52周最低
70.89
市值
2,155.18亿
市盈率(TTM)
22.76
分时
5日
1月
3月
1年
5年

分析师评级

17位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MRK 新闻

  • Merck raises quarterly dividend, to yield more than peers and the S&P 500
  • MarketWatch.16小时前
  • Merck Raises Quarterly Dividend From $0.55 To $0.61/Share
  • Benzinga.17小时前
  • Merck Announces First-Quarter 2020 Dividend
  • Business Wire.17小时前
  • FDA accepts Bioepis' application for Avastin biosimilar
  • seekingalpha.18小时前

更多

所属板块

制药
+0.40%
制药与医学研究
+0.78%

热门股票

名称
价格
涨跌幅

MRK 简况

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.
展开

Webull提供Merck & Co., Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。